Literature DB >> 7696608

In vitro effects of brain derived neurotrophic factor released from microspheres.

S Mittal1, A Cohen, D Maysinger.   

Abstract

The principal objective of these studies was to microencapsulate brain derived neurotrophic factor (BDNF) and to test its biological effects in vitro. Two types of microspheres with BDNF were prepared using biodegradable polymers: chitosan and poly-(L-lactic acid):poly-(L-glycolic acid). Depending on the procedure, sizes ranged from 1 micron to 1 mm as determined by an image analysis system. The biological assays confirmed that the released BDNF remains biologically active in vitro. Microencapsulation of BDNF and other trophic factors may represent a viable alternative to currently employed delivery systems in vivo and holds potential for eventual therapy of neurodegenerative disorders, in particular for peripheral neuropathies and CNS disorders where supplementation of neurotrophins retards or even prevents neural degeneration.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7696608     DOI: 10.1097/00001756-199412000-00043

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  5 in total

Review 1.  Bioengineered nerve regeneration and muscle reinnervation.

Authors:  Paul J Kingham; Giorgio Terenghi
Journal:  J Anat       Date:  2006-10       Impact factor: 2.610

2.  Sustained release of TGFbeta3 from PLGA microspheres and its effect on early osteogenic differentiation of human mesenchymal stem cells.

Authors:  Eduardo K Moioli; Liu Hong; Jesse Guardado; Paul A Clark; Jeremy J Mao
Journal:  Tissue Eng       Date:  2006-03

3.  Why does PEG 400 co-encapsulation improve NGF stability and release from PLGA biodegradable microspheres?

Authors:  J M Péan; F Boury; M C Venier-Julienne; P Menei; J E Proust; J P Benoit
Journal:  Pharm Res       Date:  1999-08       Impact factor: 4.200

4.  The behavioral and biochemical effects of BDNF containing polymers implanted in the hippocampus of rats.

Authors:  Rachael W Sirianni; Peter Olausson; Amy S Chiu; Jane R Taylor; W Mark Saltzman
Journal:  Brain Res       Date:  2010-01-21       Impact factor: 3.252

5.  A Safe GDNF and GDNF/BDNF Controlled Delivery System Improves Migration in Human Retinal Pigment Epithelial Cells and Survival in Retinal Ganglion Cells: Potential Usefulness in Degenerative Retinal Pathologies.

Authors:  Alicia Arranz-Romera; Maria Hernandez; Patricia Checa-Casalengua; Alfredo Garcia-Layana; Irene T Molina-Martinez; Sergio Recalde; Michael J Young; Budd A Tucker; Rocío Herrero-Vanrell; Patricia Fernandez-Robredo; Irene Bravo-Osuna
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.